MRS of pilocytic astrocytoma: The peak at 2 ppm may not be NAA

5Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: To determine whether the chemical shift of residual N-acetylaspartate (NAA) signal in pilocytic astrocytomas (PA) is consistent with the position of the NAA peak in controls. Methods: MR spectra from 27 pediatric World Health Organization (WHO) grade I pilocytic astrocytoma patients, fifteen patients with WHO grade II and high-grade (III–IV) astrocytomas, and 36 controls were analyzed. All spectra were acquired with a short echo time (35 ms), single voxel point-resolved spectroscopy sequence on clinical 3 tesla scanners. Fully automated LCModel software was used for processing, which included the fitting of peak positions for NAA and creatine (Cr). Results: The chemical shift difference between the NAA and Cr peaks was significantly smaller (by 0.016 ± 0.005 parts per million, P < 1e–10) in PAs than in controls and was also smaller than what was observed in infiltrative astrocytomas. Conclusion: The chemical shift position of the residual NAA peak in PAs is not consistent with NAA. The signal likely originates from an N-acetyl group of one or more other chemicals such as N-acetylated sugars. Magn Reson Med 78:452–456, 2017. © 2016 International Society for Magnetic Resonance in Medicine.

Cite

CITATION STYLE

APA

Tamrazi, B., Nelson, M. D., & Blüml, S. (2017). MRS of pilocytic astrocytoma: The peak at 2 ppm may not be NAA. Magnetic Resonance in Medicine, 78(2), 452–456. https://doi.org/10.1002/mrm.26374

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free